KR20130009649A - Composition for antioxidant comprising extract or fractions of rhododendron album blume as an active ingredient - Google Patents
Composition for antioxidant comprising extract or fractions of rhododendron album blume as an active ingredient Download PDFInfo
- Publication number
- KR20130009649A KR20130009649A KR1020120075544A KR20120075544A KR20130009649A KR 20130009649 A KR20130009649 A KR 20130009649A KR 1020120075544 A KR1020120075544 A KR 1020120075544A KR 20120075544 A KR20120075544 A KR 20120075544A KR 20130009649 A KR20130009649 A KR 20130009649A
- Authority
- KR
- South Korea
- Prior art keywords
- rhododendron
- extract
- fraction
- alboom
- antioxidant
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 106
- 239000000203 mixture Substances 0.000 title claims abstract description 54
- 239000004480 active ingredient Substances 0.000 title claims abstract description 27
- 240000008508 Rhododendron album Species 0.000 title claims abstract description 15
- 239000003963 antioxidant agent Substances 0.000 title claims description 45
- 230000003078 antioxidant effect Effects 0.000 title claims description 43
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 29
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims abstract description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 21
- 235000013402 health food Nutrition 0.000 claims abstract description 16
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 13
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000012223 aqueous fraction Substances 0.000 claims abstract description 7
- 241000208422 Rhododendron Species 0.000 claims description 107
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 29
- 238000000034 method Methods 0.000 claims description 20
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- 239000002537 cosmetic Substances 0.000 claims description 18
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 13
- 239000002904 solvent Substances 0.000 claims description 13
- 238000000605 extraction Methods 0.000 claims description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 2
- -1 DPPH free radical Chemical class 0.000 abstract description 17
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 abstract description 10
- 239000002038 ethyl acetate fraction Substances 0.000 abstract description 7
- 230000003064 anti-oxidating effect Effects 0.000 abstract description 6
- 230000001419 dependent effect Effects 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 5
- 239000002044 hexane fraction Substances 0.000 abstract description 5
- 239000002036 chloroform fraction Substances 0.000 abstract description 4
- 230000002292 Radical scavenging effect Effects 0.000 abstract description 2
- 229940087168 alpha tocopherol Drugs 0.000 abstract 1
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 abstract 1
- 229960000984 tocofersolan Drugs 0.000 abstract 1
- 239000002076 α-tocopherol Substances 0.000 abstract 1
- 235000004835 α-tocopherol Nutrition 0.000 abstract 1
- 235000006708 antioxidants Nutrition 0.000 description 37
- 230000007760 free radical scavenging Effects 0.000 description 30
- ZTOJFFHGPLIVKC-YAFCTCPESA-N (2e)-3-ethyl-2-[(z)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound S\1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C/1=N/N=C1/SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-YAFCTCPESA-N 0.000 description 25
- 238000002360 preparation method Methods 0.000 description 19
- 235000013305 food Nutrition 0.000 description 13
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 10
- 241000196324 Embryophyta Species 0.000 description 9
- 150000003254 radicals Chemical class 0.000 description 9
- 230000036541 health Effects 0.000 description 7
- 229930003799 tocopherol Natural products 0.000 description 7
- 239000011732 tocopherol Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 230000003712 anti-aging effect Effects 0.000 description 6
- 239000002034 butanolic fraction Substances 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 239000013641 positive control Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 6
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 229910021645 metal ion Inorganic materials 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 238000004809 thin layer chromatography Methods 0.000 description 5
- 235000010384 tocopherol Nutrition 0.000 description 5
- 229960001295 tocopherol Drugs 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 4
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- 102000019197 Superoxide Dismutase Human genes 0.000 description 4
- 108010012715 Superoxide dismutase Proteins 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 4
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 235000013365 dairy product Nutrition 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000015203 fruit juice Nutrition 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 235000012149 noodles Nutrition 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 235000014347 soups Nutrition 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 229940032147 starch Drugs 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000000080 wetting agent Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 229920002261 Corn starch Polymers 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 239000000443 aerosol Substances 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 235000015278 beef Nutrition 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 235000014121 butter Nutrition 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000008120 corn starch Substances 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 239000004088 foaming agent Substances 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 230000002000 scavenging effect Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- COHYTHOBJLSHDF-UHFFFAOYSA-N Indigo Chemical compound N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 235000004347 Perilla Nutrition 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 235000007215 black sesame Nutrition 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 235000021329 brown rice Nutrition 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000003349 gelling agent Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 235000015243 ice cream Nutrition 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229940041476 lactose 100 mg Drugs 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000003352 sequestering agent Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000019149 tocopherols Nutrition 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 235000015192 vegetable juice Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 2
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- ZTOJFFHGPLIVKC-UHFFFAOYSA-N 3-ethyl-2-[(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound S1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C1=NN=C1SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108030002440 Catalase peroxidases Proteins 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 244000180278 Copernicia prunifera Species 0.000 description 1
- 235000010919 Copernicia prunifera Nutrition 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 206010073306 Exposure to radiation Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 241000282575 Gorilla Species 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- QACUPNAKIPYZAW-RMQWDSPGSA-N O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O QACUPNAKIPYZAW-RMQWDSPGSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000282577 Pan troglodytes Species 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 238000000944 Soxhlet extraction Methods 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 235000015197 apple juice Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000010633 broth Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 235000015190 carrot juice Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 229940075614 colloidal silicon dioxide Drugs 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- 235000012495 crackers Nutrition 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 229960003949 dexpanthenol Drugs 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- LVQSCKUKDKAQGO-UHFFFAOYSA-L disodium;diiodide Chemical compound [Na+].[Na+].[I-].[I-] LVQSCKUKDKAQGO-UHFFFAOYSA-L 0.000 description 1
- 239000000386 donor Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 235000019674 grape juice Nutrition 0.000 description 1
- 235000013882 gravy Nutrition 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- 238000001794 hormone therapy Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000000852 hydrogen donor Substances 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000000367 immunologic factor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N lauric acid triglyceride Natural products CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 239000004531 microgranule Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229940069328 povidone Drugs 0.000 description 1
- 229920003124 powdered cellulose Polymers 0.000 description 1
- 235000019814 powdered cellulose Nutrition 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 150000005839 radical cations Chemical class 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 235000011649 selenium Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229920003109 sodium starch glycolate Polymers 0.000 description 1
- 229940079832 sodium starch glycolate Drugs 0.000 description 1
- 239000008109 sodium starch glycolate Substances 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 235000015193 tomato juice Nutrition 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/302—Foods, ingredients or supplements having a functional effect on health having a modulating effect on age
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medical Informatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Cosmetics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 로도덴드론 알붐(Rhododendron album Blume) 추출물 또는 이의 분획물을 유효성분으로 함유하는 항산화용 약학적 조성물, 건강식품용 조성물 및 화장료 조성물에 관한 것이다.
The present invention is Rhododendron album Blume) relates to a pharmaceutical composition for antioxidant, a health food composition and a cosmetic composition containing an extract or a fraction thereof as an active ingredient.
인체의 노화와 질병을 유발하는 자유라디칼은 인체 내에서 정상적인 대사과정 중 생물학적 반응으로 형성되며, 세포와 조직에 해로운 독성을 일으켜 여러 가지 질병을 유발하는 것으로 알려져 있다(Folin O & Denis W, 1912, J Biol Chem 12: 239-249). 이러한 유해 자유라디칼을 억제하는 생리작용으로는 산화성 자유라디칼에 전자를 공여하여 산화를 억제하는 전자공여능과 수퍼옥사이드 디스뮤타제 (superoxide dismutase)와 유사한 역할로서 반응성과 파괴성이 매우 큰 수퍼옥사이드 양이온 라디칼(superoxide anion radical)을 정상 상태의 산소로 전환시켜주는 역할이 있다. Free radicals that cause aging and disease in the human body are formed by biological reactions during normal metabolic processes in the human body, and are known to cause various diseases by causing harmful toxicity to cells and tissues (Folin O & Denis W, 1912, J Biol Chem 12: 239-249). The physiological action of inhibiting such harmful free radicals is similar to that of an electron donating ability and a superoxide dismutase which inhibits oxidation by donating electrons to oxidative free radicals. It converts superoxide anion radicals into normal oxygen.
강력한 항산화 효과를 가지는 여러 가지 생리활성 성분들은 산화적 스트레스에 의해 발생되는 궤양과 경련의 예방, 위장관의 위액 분비조절과 설사예방, 당뇨예방, 암, 심장병 및 퇴행성 질병들의 예방과 감소에 크게 기여한다고 보고되고 있다(Azuma K et al., 1999, J Agric Food Chem 47: 3963-3966, Ham SS et al., 1997, J Food Sci Nutr 2:155-161). 또한 최근 건강에 대한 관심이 높아지면서 다양한 식물자원에서 항암, 항알러지, 항비만, 항산화 및 항균 등의 효과가 있는 기능성 물질을 다량 함유하는 자원을 선발하여 약품, 식품첨가제 및 화장품의 원료로 개발하려는 연구가 전 세계적으로 진행되고 있다(Shin DB, et al., 2006, Food Sci Biotechnol., 15: 357-362, Park et al., 2004, Korean J Nutr, 37: 364-372, Kim et al., 2006, Kor J Food Sci. Technol. 38: 799-804, Ali KA et al., 2005, Food Chem., 89: 27-36). Many bioactive ingredients with powerful antioxidant effects contribute greatly to the prevention of ulcers and spasms caused by oxidative stress, control of gastric juice secretion and diarrhea, prevention of diabetes, prevention of cancer, heart disease and degenerative diseases. Azuma K et al., 1999, J Agric Food Chem 47: 3963-3966, Ham SS et al., 1997, J Food Sci Nutr 2: 155-161. In addition, as interest in health has recently increased, various plant resources have been selected to develop resources containing a large amount of functional substances, such as anti-cancer, anti-allergy, anti-obesity, antioxidant, and antibacterial, and to develop them as raw materials for pharmaceuticals, food additives, and cosmetics. Research is underway worldwide (Shin DB, et al., 2006, Food Sci Biotechnol., 15: 357-362, Park et al., 2004, Korean J Nutr, 37: 364-372, Kim et al. , 2006, Kor J Food Sci.Technol. 38: 799-804, Ali KA et al., 2005, Food Chem., 89: 27-36).
항산화제인 수퍼옥사이드 디스뮤타제(Superoxide dismutase, SOD)는 세포의 호흡과정에서 발행한 활성산소 즉, 수퍼옥사이드 라디칼(Superoxide radical, O2-)을 과산화수소와 산소로 분해시킨다. 수퍼옥사이드 라디칼 자체는 반응성이 비교적 약하지만, 쉽게 H2O2로 변환되어 반응성이 강한 하이드록실 라디칼을 생성하거나, 나이트릭 옥사이드(nitric oxide, NO)와 반응하여 반응성이 강한 퍼옥시나이트라이트(peroxy nitrite, ONOO-)를 생성하여 SH-그룹의 산화, 단백질 티로신의 질산화(nitration), 지질과산화, DNA 손상 등을 일으키는 원인이 된다. 수퍼옥사이드 디스뮤타제에 의한 분해산물인 과산화수소가 철이나 동이온과 같은 금속이온과 결합하여 반응을 하게 되면 하이드록시 라디칼이라는 보다 강력한 활성산소가 발생하게 된다. 과산화수소가 금속이온과 반응하기 전에 이를 제거해주는 항산화제인 카탈라아제와 글루타치온 퍼옥시다제가 과산화수소를 물과 이산화탄소로 분해를 시켜준다. 항산화제가 제거하지 못한 전체 과산화수소의 5%가 체내의 금속이온에 반응하여 하이드록시 라디칼로 변해 세포를 파괴하고, 질병의 원인으로 작용한다. 방사선이나 자외선의 잦은 노출은 과산화수소를 하이드록시 라디칼로 변하게 하여 노화를 촉진시키는 데, 이를 지연시키는 방법으로는 항산화제의 복용이 있다. Superoxide dismutase (SOD), an antioxidant, breaks down free radicals (Superoxide radicals, O 2- ), which are issued during cell respiration, into hydrogen peroxide and oxygen. Superoxide radicals themselves have relatively low reactivity, but are easily converted to H 2 O 2 to form highly reactive hydroxyl radicals or react with nitric oxides (NO) to form highly reactive peroxy nitrites. nitrite, ONOO - generate) to causes such as the oxidation of SH- groups, protein tyrosine nitride (nitration), lipid peroxidation, DNA damage. When hydrogen peroxide, a product of decomposition by superoxide dismutase, reacts with metal ions such as iron or copper ions, a more powerful active oxygen called a hydroxy radical is generated. The antioxidants catalase and glutathione peroxidase, which remove hydrogen peroxide before it reacts with metal ions, decompose hydrogen peroxide into water and carbon dioxide. 5% of the total hydrogen peroxide that antioxidants can't remove turns into hydroxy radicals in response to metal ions in the body, destroying cells and causing disease. Frequent exposure to radiation or ultraviolet light converts hydrogen peroxide into hydroxy radicals to promote aging, which can be delayed by taking antioxidants.
자유라디칼 소거능을 측정하는 방법으로 DPPH는 항산화 물질로부터 전자나 수소를 받아 비가역적으로 안정한 분자를 형성하므로 전자공여능으로부터 항산화 활성을 측정할 수 있는데, 항산화 활성이 있는 물질과 만나면 자유라디칼(free radical)이 소거되며 이때의 DPPH 고유의 청남색이 엷어지는 특성이 있고, 이 색차를 비색 정량하여 전자공여능력을 측정한다(Jeon et al., J. Kor. Soc. Food sic. Nutr. 38(1): 1-8, 2009). 또한, ABTS법은 1993년에 시료의 생리활성을 측정하기 위해 고안된 방법이지만, 이후 식품과 천연 수용성 페놀성 물질을 시험하기 위해 널리 응용되었다. ABTS[2,2′-azinobis(3-ethyl-benzo-thiaziline-6-sulfonate)]와 포타슘 퍼설페이트(potassium persulfate)의 혼합으로 생성된 청록색의 라디칼 양이온( ABTS·+)이 페놀성 화합물과 같은 수소공여체 (H-donor)와 강렬하게 반응하여 무색으로 변하는데, 이것을 정량하여 전자공여능력을 측정한다(Miller et al., Clin. Sci . 26: 265-277, 1993).
As a method of measuring free radical scavenging ability, DPPH receives an electron or hydrogen from an antioxidant and forms an irreversibly stable molecule. Therefore, it can measure antioxidant activity from an electron donating ability. At this time, there is a characteristic that the indigo blue color inherent in DPPH is thinned, and the color difference is measured to measure the electron donating ability (Jeon et al., J. Kor. Soc. Food sic. Nutr. 38 (1)). : 1-8, 2009). In addition, the ABTS method was designed in 1993 to measure the physiological activity of a sample, but has since been widely applied to test foods and naturally soluble phenolic substances. The cyan radical cation (ABTS · + ) produced by the mixture of ABTS [2,2′-azinobis (3-ethyl-benzo-thiaziline-6-sulfonate)] and potassium persulfate is the same as the phenolic compound. It reacts violently with a hydrogen donor (H-donor) to become colorless, and quantitatively measures the electron donating ability (Miller et al., Clin. Sci . 26: 265-277, 1993).
항산화물질은 동·식물계에 널리 분포되어 있는데, 과일과 채소에 많은 페놀성 화합물, 플라보노이드, 토코페롤, 비타민 C, 셀레늄과 같은 항산화물질은 지방의 산화를 지연시키거나 방지하며, 암, 심장혈관계 질환 등을 예방, 지연시킴으로써 노화방지에도 중요한 역할을 한다. 식물계에 존재하는 천연 항산화물질인 토코페롤과 비타민 C는 식품, 의약품 및 화장품 등에 널리 이용되고 있다. 유지 또는 유지함유 식품의 산패는 주로 공기 중의 산소와 결합에 의해 일어나는데, 이를 방지하기 위하여 많은 합성 또는 천연 항산화 물질이 개발되어 왔으나, 그 효과와 경제성 때문에 실제로 많이 사용되고 있는 것은 합성 항산화제이다. Antioxidants are widely distributed in animals and plants. Antioxidants such as phenolic compounds, flavonoids, tocopherols, vitamin C, and selenium in fruits and vegetables delay or prevent the oxidation of fats, and cancer, cardiovascular diseases, etc. By preventing and delaying, it plays an important role in preventing aging. Tocopherols and vitamin C, which are natural antioxidants present in the plant kingdom, are widely used in food, medicine, and cosmetics. The rancidity of fats and oils or foods containing oils and fats is mainly caused by the combination with oxygen in the air. To prevent this, many synthetic or natural antioxidants have been developed.
합성 항산화제로는 뷰틸레이트하이드록시톨루엔(Butylated Hydroxy Toluene, BHT), 뷰틸하이드록시아니솔(Butylated Hydroxy Anisole, BHA), 갈산프로필(Propyl Gallate) 등이 있다. 합성 항산화제는 항산화력이 뛰어나고 가격이 저렴하여 상업용 식품에 많이 사용되고 있으나, 인체 부작용 등 안정성에 대한 우려로 사용량이 법적으로 규제되어 있다. 토코페롤과 같은 천연 항산화제는 인체에 대하여 안전하기는 하나 단독으로는 산화 연쇄반응 저해 능력이 낮고, 가격이 비싼 단점이 있다. 따라서, 최근에는 보다 안전하고 항산화 효과가 뛰어난 천연 항산화제를 개발하기 위한 연구가 활발히 이루어지고 있다. Synthetic antioxidants include Butylated Hydroxy Toluene (BHT), Butylated Hydroxy Anisole (BHA), Propyl Gallate, and the like. Synthetic antioxidants are widely used in commercial foods because of their excellent antioxidant power and low price, but their usage is legally regulated due to concerns about stability, such as human side effects. Natural antioxidants, such as tocopherol, are safe for the human body, but have the disadvantage of low oxidative chain reaction inhibition ability and high price. Therefore, in recent years, researches are being actively conducted to develop safer and more natural antioxidants.
로도덴드론 알붐은 진달래과에 속하는 인도네시아의 토속 식물이다. 이 식물은 백색이며, 변종의 경우 엷은 자색을 띄기도 한다. 수술은 오렌지 또는 분홍색을 띈다 (Bay Science Foundation, 2008). 이 식물의 서식환경은 벌목, 농작물 경작, 기반시설의 확장 등의 이유로 서식지의 감소로 인해 종의 위협을 받고 있다(Whitten et al. 1996). 또한, 이 식물은 미적 가치가 높은 이유로 전 세계, 특히 미국에서는 변종, 대표적으로 Rhododendron cawtawbiencse var. album 같은 식물을 개발하여 조경산업에 활용하고 있다(Paghat, 2008). 그러나, 현재 로도덴드론 알붐(Rhododendron album Blume)추출물에 대한 항산화 효과는 보고된 바 없다.
Rhododendron Alboom is a native plant of Indonesia that belongs to the rhododendron. The plant is white and in some cases light purple. Surgery was orange or pink (Bay Science Foundation, 2008). The habitats of these plants are threatened with species due to habitat loss for reasons of logging, crop cultivation and expansion of infrastructure (Whitten et al. 1996). In addition, this plant has a variety of varieties worldwide, especially in the United States, because of its high aesthetic value, typically Rhododendron. cawtawbiencse var. album The same plant is being developed and used in the landscape industry (Paghat, 2008). However, no antioxidant effect has been reported on Rhododendron album Blume extract at present.
이에, 본 발명자들은 항산화 효과가 우수한 식물을 스크리닝하던 중, 로도덴드론 알붐 추출물 또는 이의 분획물이 우수한 DPPH(1,1-diphenyl-2-picryl-hydrazyl) 자유라디칼 소거 효과 및 ABTS(2,2'-azinobis-(3-ethylbenzothiazoline-6-sulfonate)) 자유라디칼 소거 효과를 나타내어 탁월한 항산화 효과를 가지고 있음을 확인하였으므로, 항산화용 조성물의 유효성분으로 유용하게 사용될 수 있음을 밝힘으로써 본 발명을 완성하였다.
Accordingly, the inventors of the present invention, while screening plants with excellent antioxidant effects, Rhododendron alboom extract or its fractions are excellent DPPH (1,1-diphenyl-2-picryl-hydrazyl) free radical scavenging effect and ABTS (2,2 ' -azinobis- (3-ethylbenzothiazoline-6-sulfonate)) Since the free radical scavenging effect was confirmed to have an excellent antioxidant effect, the present invention was completed by revealing that it can be usefully used as an active ingredient of the antioxidant composition.
본 발명의 목적은 로도덴드론 알붐(Rhododendron album Blume) 추출물 또는 이의 분획물을 유효성분으로 함유하는 항산화용 약학적 조성물, 건강식품용 조성물 및 화장료 조성물을 제공하는 것이다.
An object of the present invention is to provide an antioxidant pharmaceutical composition, health food composition and cosmetic composition containing Rhododendron album Blume extract or fractions thereof as an active ingredient.
상기 목적을 달성하기 위하여, 본 발명은 로도덴드론 알붐(Rhododendron album Blume) 추출물 또는 이의 분획물을 유효성분으로 함유하는 항산화용 약학적 조성물을 제공한다.In order to achieve the above object, the present invention provides a pharmaceutical composition for antioxidant containing Rhododendron album Blume extract or a fraction thereof as an active ingredient.
또한, 본 발명은 로도덴드론 알붐 추출물 또는 이의 분획물을 유효성분으로 함유하는 항산화용 건강식품용 조성물을 제공한다.In addition, the present invention provides a composition for health food for antioxidation containing Rhodendron aroma extract or a fraction thereof as an active ingredient.
아울러, 본 발명은 로도덴드론 알붐 추출물 또는 이의 분획물을 유효성분으로 함유하는 항산화용 화장료 조성물을 제공한다.
In addition, the present invention provides a cosmetic composition for antioxidant containing Rhododendron alboom extract or fractions thereof as an active ingredient.
본 발명은 로도덴드론 알붐(Rhododendron album Blume) 추출물 또는 이의 분획물을 유효성분으로 함유하는 항산화용 조성물에 관한 것으로, 보다 구체적으로 본 발명의 로도덴드론 알붐 추출물 또는 이의 분획물은 유의적인 DPPH 자유라디칼 소거 효과 및 ABTS 자유라디칼 소거 효과를 나타내어 탁월한 항산화 효과를 가짐으로써, 항산화용 약학적 조성물, 건강식품용 조성물 및 화장료 조성물의 유효성분으로 유용하게 사용될 수 있다.
The present invention is Rhododendron album The present invention relates to an antioxidant composition containing Blume) extract or a fraction thereof as an active ingredient. More specifically, the Rhododendron alboom extract of the present invention or a fraction thereof exhibits significant DPPH free radical scavenging effect and ABTS free radical scavenging effect. By having an antioxidant effect, it can be usefully used as an active ingredient of the pharmaceutical composition for antioxidant, the composition for health food and the cosmetic composition.
도 1은 로도덴드론 알붐(Rhododendron album Blume) 추출물과 분획물의 제조과정을 나타낸 도이다.
도 2는 로도덴드론 알붐 추출물과 분획물의 TLC(Thin Layer Chromatography)를 나타낸 도이다:
T: 로도덴드론 알붐 추출물;
H: 로도덴드론 알붐 n-헥산 분획물;
C: 로도덴드론 알붐 클로로포름 분획물;
E: 로도덴드론 알붐 에틸아세테이트 분획물;
B: 로도덴드론 알붐 부탄올 분획물; 및
W: 로도덴드론 알붐 물 분획물.
도 3은 로도덴드론 알붐 추출물 또는 이의 분획물의 CAD(Charge Aerosol Detector)를 나타낸 도이다.
도 4는 로도덴드론 알붐 추출물의 DPPH 자유라디칼 소거 효과를 나타낸 그래프이다.
도 5는 로도덴드론 알붐 추출물의 ABTS 자유라디칼 소거 효과를 나타낸 그래프이다.1 is a Rhododendron album Blume) is a diagram showing the manufacturing process of extracts and fractions.
2 is a diagram showing Thin Layer Chromatography (TLC) of Rhododendron Alboom extract and fractions:
T: rhododendron alboom extract;
H: rhododendron alboom n-hexane fraction;
C: rhododendron alboom chloroform fraction;
E: rhododendron alboom ethyl acetate fraction;
B: rhododendron alboom butanol fraction; And
W: Rhododendron Alboom water fraction.
Figure 3 is a diagram showing a CAD (Charge Aerosol Detector) of the rhododendron alboom extract or fractions thereof.
Figure 4 is a graph showing the DPPH free radical scavenging effect of the rhododendron alboom extract.
5 is a graph showing the ABTS free radical scavenging effect of the rhododendron alboom extract.
이하, 본 발명을 상세히 설명한다.
Hereinafter, the present invention will be described in detail.
본 발명은 로도덴드론 알붐(Rhododendron album Blume) 추출물 또는 이의 분획물을 유효성분으로 함유하는 항산화용 약학적 조성물을 제공한다.The present invention is Rhododendron album Blume) provides an antioxidant pharmaceutical composition containing an extract or a fraction thereof as an active ingredient.
또한, 본 발명은 로도덴드론 알붐 추출물(Rhododendron album Blume) 또는 이의 분획물을 유효성분으로 함유하는 노화방지용 약학적 조성물을 제공한다.In addition, the present invention Rhododendron alboom extract ( Rhododendron album Blume) or a fraction thereof is provided as an anti-aging pharmaceutical composition.
상기 로도덴드론 알붐 추출물(Rhododendron album Blume)은 하기의 단계들을 포함하는 제조방법에 의해 제조되는 것이 바람직하나 이에 한정되지 않는다: Rhododendron alboom extract ( Rhododendron album Blume) is preferably prepared by a manufacturing method comprising the following steps, but not limited to:
1) 로도덴드론 알붐에 추출용매를 가하여 추출하는 단계;1) extracting by adding an extraction solvent to the Rhododendron alboom;
2) 단계 1)의 추출물을 여과하는 단계; 및2) filtering the extract of step 1); And
3) 단계 2)의 여과한 추출물을 감압 농축한 후 건조하여 로도덴드론 알붐의 추출물을 제조하는 단계.3) concentrating the filtered extract of step 2) under reduced pressure and drying to prepare an extract of rhododendron alboom.
상기 방법에 있어서, 단계 1)의 로도덴드론 알붐은 재배한 것 또는 시판되는 것 등 제한 없이 사용할 수 있다. 상기 로도덴드론 알붐은 잎, 줄기 또는 뿌리가 모두 이용가능하다. In the above method, the Rhododendron alboom of step 1) can be used without limitation, such as grown or commercially available. The Rhododendron alboom is available in both leaves, stems or roots.
상기 방법에 있어서, 상기 단계 1)의 추출용매는 물, 알코올 또는 이들의 혼합물을 사용하는 것이 바람직하다. 상기 알코올로는 C1 내지 C2 저급 알코올을 이용하는 것이 바람직하며, 저급 알코올로는 에탄올 또는 메탄올을 이용하는 것이 바람직하고, 메탄올을 이용하는 것이 가장 바람직하나, 이에 한정하지 않는다. 추출방법으로는 진탕추출, Soxhlet 추출 또는 환류 추출을 이용하는 것이 바람직하나 이에 한정되지 않는다. 상기 추출용매를 건조된 로도덴드론 알붐 분량에 1 내지 10배 첨가하여 추출하는 것이 바람직하고, 2 내지 3배 첨가하여 추출하는 것이 더욱 바람직하나, 이에 한정하지 않는다. 추출온도는 20 내지 100℃인 것이 바람직하고, 20 내지 40℃인 것이 바람직하나, 이에 한정하지 않는다. 또한, 추출시간은 10 내지 48시간인 것이 바람직하며, 15 내지 30시간인 것이 더욱 바람직하나 이에 한정하지 않는다. 아울러, 추출 횟수는 1 내지 5회인 것이 바람직하며, 3 내지 4회 반복 추출하는 것이 더욱 바람직하나 이에 한정되는 것은 아니다. In the above method, the extraction solvent of step 1) is preferably water, alcohol or a mixture thereof. As the alcohol, C 1 to C 2 lower alcohols are preferably used, and as lower alcohols, ethanol or methanol is preferably used, and methanol is most preferably used, but not limited thereto. As the extraction method, it is preferable to use shaking extraction, Soxhlet extraction or reflux extraction, but is not limited thereto. The extraction solvent is preferably extracted by adding 1 to 10 times to the dried Rhododendron alboom, and more preferably by adding 2 to 3 times, but not always limited thereto. The extraction temperature is preferably 20 to 100 ° C, preferably 20 to 40 ° C, but is not limited thereto. In addition, the extraction time is preferably 10 to 48 hours, more preferably 15 to 30 hours, but is not limited thereto. In addition, the number of extraction is preferably 1 to 5 times, more preferably 3 to 4 times repeated extraction is not limited thereto.
상기 방법에 있어서, 단계 3)의 감압농축은 진공감압농축기 또는 진공회전증발기를 이용하는 것이 바람직하나 이에 한정하지 않는다. 또한, 건조는 감압건조, 진공건조, 비등건조, 분무건조 또는 동결건조하는 것이 바람직하나 이에 한정하지 않는다.In the above method, it is preferable to use a vacuum decompression concentrator or a vacuum rotary evaporator for the decompression concentration in step 3), but it is not limited thereto. In addition, the drying is preferably reduced pressure drying, vacuum drying, boiling drying, spray drying or freeze drying, but is not limited thereto.
또한, 상기 로도덴드론 알붐 추출물의 분획물은 다음과 같이 제조되는 것이 바람직하나 이에 한정하지 않는다.In addition, the fraction of the rhododendron alboom extract is preferably prepared as follows, but is not limited thereto.
1) 로도덴드론 알붐 추출물을 물에 현탁한 후, n-헥산을 가하여 n-헥산층을 분리하는 단계;1) suspending the rhododendron alboom extract in water, and then separating n-hexane layer by adding n-hexane;
2) 단계 1)의 남은 물층에 클로로포름을 가하여 클로로포름 층을 분리하는 단계;2) separating the chloroform layer by adding chloroform to the remaining water layer of step 1);
3) 단계 2)의 남은 물층에 에틸아세테이트를 가하여 에틸아세테이트 층을 분리하는 단계; 3) adding ethyl acetate to the remaining water layer of step 2) to separate the ethyl acetate layer;
4) 단계 3)의 남은 물층에 부탄올을 가하여 부탄올 층을 분리하는 단계; 및4) separating butanol layer by adding butanol to the remaining water layer of step 3); And
5) 단계 4)의 남은 물층에 물 분획물을 분리하는 단계.5) separating the water fraction in the remaining water layer of step 4).
상기 방법에 있어서, 상기 유기용매는 노르말-헥산, 클로로포름, 에틸아세테이트 또는 노르말-부탄올인 것이 바람직하나 이에 한정하지 않는다. 상기 분획물은 상기 로도덴드론 알붐 추출물로부터 분획 과정을 1 내지 5회, 바람직하게는 3회 반복하여 수득할 수 있고, 분획 후 감압 농축하는 것이 바람직하나 이에 한정하지 않는다.In the above method, the organic solvent is preferably, but not limited to, normal-hexane, chloroform, ethyl acetate, or normal-butanol. The fraction may be obtained by repeating the fractionation process 1 to 5 times, preferably 3 times from the Rhododendron alboom extract, preferably concentrated under reduced pressure after the fraction, but is not limited thereto.
상기 유기용매는 에틸아세테이트 또는 부탄올인 것이 보다 바람직하다.The organic solvent is more preferably ethyl acetate or butanol.
본 발명의 구체적인 실시예에서, 본 발명자들은 로도덴드론 알붐 추출물은 한국생명공학연구원 해외생물소재허브센터의 해외식물추출물은행에서 구입하였으며, 상기 로도덴드론 알붐 추출물을 이용하여 로도덴드론 알붐 분획물을 제조하였다(도 1 참조). In a specific embodiment of the present invention, the present inventors purchased the Rhododendron alboom extract from the Overseas Plant Extract Bank of the Korea Center for Biomaterials, Korea Research Institute of Bioscience and Biotechnology, and uses the Rhododendron alboom extract to extract the rhododendron alboom fraction. Prepared (see FIG. 1).
또한, 본 발명의 또 다른 구체적인 실시예에서, 로도덴드론 알붐 추출물 또는 이의 분획물의 TLC 조사 및 UPLC 조사를 수행하였다(도 2 및 도 3 참조).Further, in another specific embodiment of the present invention, TLC irradiation and UPLC irradiation of the rhododendron alboom extract or fractions thereof were performed (see FIGS. 2 and 3).
또한, 본 발명의 또 다른 구체적인 실시예에서, 로도덴드론 알붐 추출물의 항산화 효과를 확인하기 위하여, DPPH 자유라디칼 소거 효과를 1,1-디페닐-2-피크릴-하이드라질(1,1-diphenyl-2-picryl-hydrazyl, DPPH, Sigma) 방법으로 측정한 결과, 로도덴드론 알붐 추출물이 농도의존적으로 DPPH 자유라디칼의 소거 효과를 나타내는 것을 확인하였다(도 4 참조).In addition, in another specific embodiment of the present invention, in order to confirm the antioxidant effect of the rhododendron alboom extract, DPPH free radical scavenging effect of 1,1-diphenyl-2-picryl-hydrazil (1,1- As measured by diphenyl-2-picryl-hydrazyl, DPPH, Sigma) method, it was confirmed that the rhododendron alboom extract showed the scavenging effect of DPPH free radicals in a concentration-dependent manner (see FIG. 4).
또한, 본 발명의 또 다른 구체적인 실시예에서, 로도덴드론 알붐 추출물의 항산화 효과를 확인하기 위하여, 로도덴드론 알붐 추출물의 다양한 농도에 따른 ABTS 자유라디칼 소거 효과를 측정한 결과, 로도덴드론 알붐 추출물이 농도의존적으로 ABTS 자유라디칼의 소거 효과를 나타내는 것을 확인하였다(도 5 참조).In addition, in another specific embodiment of the present invention, in order to confirm the antioxidant effect of the rhododendron alboom extract, as a result of measuring the ABTS free radical scavenging effect according to various concentrations of the rhododendron alboom extract, the rhododendron alboom extract It was confirmed that this concentration-dependent scavenging effect of the ABTS free radicals (see Fig. 5).
또한, 본 발명의 또 다른 구체적인 실시예에서, 로도덴드론 알붐 분획물의 DPPH 및 ABTS 자유라디칼 소거능을 확인한 결과, 로도덴드론 알붐 용매 분획물은 DPPH 및 ABTS 자유라디칼 소거 효과가 뛰어남을 확인하였고, 특히 로도덴드론 알붐 에틸아세테이트 및 부탄올 분획물은 DPPH 및 ABTS 자유라디칼 소거 효과가 현저히 높은 것을 확인하였으며, 또한 천연물 유래의 양성대조군인 a-토코페롤과 아스코르브산을 처리한 군과 비교하였을 때도 월등히 우수한 활성을 나타냄을 확인하였다(표 1 참조).In addition, in another specific embodiment of the present invention, as a result of confirming the DPPH and ABTS free radical scavenging ability of the rhododendron alboom fraction, it was confirmed that the rhododendron alboom solvent fraction was excellent in DPPH and ABTS free radical scavenging effect, in particular Rhodo The dendron alboom ethyl acetate and butanol fractions were found to have significantly higher DPPH and ABTS free radical scavenging effects, and also showed significantly better activity compared to the a-tocopherol and ascorbic acid treatment groups, which were derived from natural products. It was confirmed (see Table 1).
따라서, 본 발명의 로도덴드론 알붐 추출물 또는 이의 분획물은 농도의존적으로 DPPH 자유라디칼 소거 효과 및 ABTS 자유라디칼 소거 효과를 나타내어 탁월한 항산화 효과를 가지므로, 항산화용 약학적 조성물 또는 노화방지용 약학적 조성물의 유효성분으로 유용하게 사용될 수 있음을 알 수 있다.
Therefore, the rhododendron alboom extract or fractions thereof of the present invention exhibit DPPH free radical scavenging effect and ABTS free radical scavenging effect in a concentration-dependent manner, and thus have an excellent antioxidant effect, and thus are effective for antioxidant or anti-aging pharmaceutical compositions. It can be seen that it can be usefully used as a component.
본 발명의 로도덴드론 알붐 추출물 또는 이의 분획물을 함유하는 조성물은 상기 성분에 추가로 동일 또는 유사한 기능을 나타내는 유효성분을 1종 이상 함유할 수 있다. The composition containing the rhododendron alboom extract of the present invention or a fraction thereof may further contain one or more active ingredients exhibiting the same or similar functions in addition to the above components.
본 발명의 조성물은 약제학적으로 허용 가능한 첨가제를 더 포함할 수 있으며, 이때 약제학적으로 허용 가능한 첨가제로는 전분, 젤라틴화 전분, 미결정셀룰로오스, 유당, 포비돈, 콜로이달실리콘디옥사이드, 인산수소칼슘, 락토스, 만니톨, 엿, 아라비아고무, 전호화전분, 옥수수전분, 분말셀룰로오스, 히드록시프로필셀룰로오스, 오파드라이, 전분글리콜산나트륨, 카르나우바 납, 합성규산알루미늄, 스테아린산, 스테아린산마그네슘, 스테아린산알루미늄, 스테아린산칼슘, 백당, 덱스트로스, 소르비톨 및 탈크 등이 사용될 수 있다. 본 발명에 따른 약제학적으로 허용 가능한 첨가제는 상기 조성물에 대해 0.1 ~ 90 중량부 포함되는 것이 바람직하나 이에 한정되는 것은 아니다.The composition of the present invention may further comprise a pharmaceutically acceptable additive, wherein the pharmaceutically acceptable additive may include starch, gelatinized starch, microcrystalline cellulose, lactose, povidone, colloidal silicon dioxide, calcium hydrogen phosphate, lactose , Mannitol, malt, gum arabic, pregelatinized starch, corn starch, powdered cellulose, hydroxypropyl cellulose, opiodry, sodium starch glycolate, lead carnauba, synthetic aluminum silicate, stearic acid, magnesium stearate, aluminum stearate, calcium stearate , Sucrose, dextrose, sorbitol, talc and the like can be used. The pharmaceutically acceptable additive according to the present invention is preferably included 0.1 to 90 parts by weight based on the composition, but is not limited thereto.
즉, 본 발명의 조성물은 실제 임상 투여 시에 경구 및 비경구의 여러 가지 제형으로 투여될 수 있는데, 제제화할 경우에는 보통 사용하는 충진제, 증량제, 결합제, 습윤제, 붕해제, 계면활성제 등의 희석제 또는 부형제를 사용하여 조제될 수 있다. 경구투여를 위한 고형제제에는 정제, 환제, 산제, 과립제, 캡슐제 등이 포함되며, 이러한 고형제제는 로도덴드론 알붐 추출물 또는 이의 분획물에 적어도 하나 이상의 부형제 예를 들면, 전분, 칼슘카보네이트(Calcium carbonate), 수크로스(Sucrose), 락토오스(Lactose) 또는 젤라틴 등을 섞어 조제될 수 있다. 또한, 단순한 부형제 이외에 마그네슘 스티레이트 탈크 같은 윤활제들도 사용될 수 있다. 경구를 위한 액상 제제로는 현탁제, 내용액제, 유제 및 시럽제 등이 해당되는데 흔히 사용되는 단순희석제인 물, 리퀴드 파라핀 이외에 여러 가지 부형제, 예를 들면 습윤제, 감미제, 방향제, 보존제 등이 포함될 수 있다. 비경구 투여를 위한 제제에는 멸균된 수용액, 비수성용제, 현탁제, 유제, 동결건조제제, 좌제가 포함될 수 있다. 비수성용제, 현탁용제로는 프로필렌글리콜(Propylene glycol), 폴리에틸렌 글리콜, 올리브 오일과 같은 식물성 기름, 에틸올레이트와 같은 주사 가능한 에스테르 등이 사용될 수 있다. 좌제의 기제로는 위텝솔(witepsol), 마크로골, 트윈(tween) 61, 카카오지, 라우린지, 글리세로제라틴 등이 사용될 수 있다.That is, the composition of the present invention can be administered in various oral and parenteral formulations during actual clinical administration, and when formulated, diluents or excipients such as fillers, extenders, binders, wetting agents, disintegrating agents, surfactants, etc., which are commonly used It can be prepared using. Solid preparations for oral administration include tablets, pills, powders, granules, capsules and the like, and such solid preparations may contain at least one excipient such as starch, calcium carbonate (Rhododendron Alboom Extract or fractions thereof). ), Sucrose (Sucrose), lactose (Lactose) or gelatin can be prepared by mixing. In addition to simple excipients, lubricants such as magnesium styrate talc may also be used. Oral liquid preparations include suspensions, solvents, emulsions, and syrups, and may include various excipients, such as wetting agents, sweeteners, fragrances, and preservatives, in addition to commonly used simple diluents, water and liquid paraffin. . Formulations for parenteral administration may include sterile aqueous solutions, non-aqueous solvents, suspensions, emulsions, lyophilized preparations, suppositories. As the non-aqueous solvent and the suspension solvent, propylene glycol, polyethylene glycol, vegetable oil such as olive oil, injectable ester such as ethyl oleate, and the like can be used. As the base of the suppository, witepsol, macrogol, tween 61, cacao butter, laurin butter, glycerogelatin and the like can be used.
본 발명의 조성물은 목적하는 방법에 따라 경구 투여하거나 비경구 투여할 수 있으며, 비경구 투여시 피부 외용 또는 복강내주사, 직장내주사, 피하주사, 정맥주사, 근육내 주사 또는 흉부내 주사 주입방식을 선택하는 것이 바람직하다. 투여량은 환자의 체중, 연령, 성별, 건강상태, 식이, 투여시간, 투여방법, 배설율 및 질환의 중증도 등에 따라 그 범위가 다양하다.The composition of the present invention may be administered orally or parenterally according to a desired method, and when administered parenterally, external skin or intraperitoneal injection, rectal injection, subcutaneous injection, intravenous injection, intramuscular injection or intrathoracic injection injection method It is preferable to select. Dosage ranges depending on the patient's weight, age, sex, health condition, diet, time of administration, method of administration, rate of excretion and the severity of the disease.
본 발명의 조성물의 투여량은 환자의 체중, 연령, 성별, 건강상태, 식이, 투여시간, 투여방법, 배설율 및 질환의 중증도에 따라 그 범위가 다양하며, 일일 투여량은 로도덴드론 알붐 추출물 또는 이의 분획물의 양을 기준으로 0.0001 내지 100 ㎎/㎏이고, 바람직하게는 0.001 내지 10 ㎎/㎏이며, 하루 1 ~ 6 회 투여될 수 있다.The dosage of the composition of the present invention varies depending on the weight, age, sex, health status, diet, time of administration, administration method, excretion rate and severity of the disease of the patient, the daily dosage is Rhododendron alboom extract Or 0.0001 to 100 mg / kg, preferably 0.001 to 10 mg / kg, based on the amount of fractions thereof, and may be administered 1 to 6 times per day.
본 발명의 조성물은 단독으로, 또는 수술, 방사선 치료, 호르몬 치료, 화학 치료 및 생물학적 반응 조절제를 사용하는 방법들과 병용하여 사용할 수 있다.
The composition of the present invention may be used alone or in combination with methods using surgery, radiation therapy, hormone therapy, chemotherapy, and biological response modifiers.
또한, 본 발명은 약학적으로 유효한 양의 로도덴드론 알붐 추출물 또는 이의 분획물을 개체에 투여하는 단계를 포함하는 노화억제 방법을 제공한다.The present invention also provides a method for inhibiting aging comprising administering to a subject a pharmaceutically effective amount of rhododendron alboom extract or a fraction thereof.
상기 약학적으로 유효한 양이란 0.00001 내지 10 mg/kg이고, 바람직하게는 0.0001 내지 1 mg/kg이나 이에 한정하지 않는다. 투여량은 특정 환자의 체중, 연령, 성별, 건강상태, 식이, 투여기간, 투여방법, 제거율, 질환의 중증도 등에 따라 변화될 수 있다. The pharmaceutically effective amount is 0.00001 to 10 mg / kg, preferably 0.0001 to 1 mg / kg, but is not limited thereto. The dose may vary depending on the weight, age, sex, health condition, diet, administration period, method of administration, rate of elimination, severity of disease, and the like of a particular patient.
상기 개체는 척추동물이고 바람직하게는 포유동물이며, 그보다 바람직하게는 쥐, 토끼, 기니아피그, 햄스터, 개, 고양이와 같은 실험동물이고, 가장 바람직하게는 침팬지, 고릴라와 같은 유인원류 동물이다. The subject is a vertebrate and preferably a mammal, more preferably an experimental animal such as a rat, rabbit, guinea pig, hamster, dog, cat, and most preferably an ape-like animal such as a chimpanzee or gorilla.
상기 투여 방법은 경구 또는 비경구가 바람직하며, 피부 도포가 가장 바람직하다.
The administration method is preferably oral or parenteral, most preferably skin application.
또한, 본 발명은 로도덴드론 알붐 추출물 또는 이의 분획물을 유효성분으로 함유하는 항산화용 건강식품용 조성물을 제공한다.In addition, the present invention provides a composition for health food for antioxidation containing Rhodendron aroma extract or a fraction thereof as an active ingredient.
또한, 본 발명은 로도덴드론 알붐 추출물 또는 이의 분획물을 유효성분으로 함유하는 노화방지용 건강식품용 조성물을 제공한다.The present invention also provides an anti-aging health food composition containing the rhododendron alboom extract or fractions thereof as an active ingredient.
본 발명의 건강식품용 조성물은 로도덴드론 알붐 추출물 또는 이의 분획물을 그대로 첨가하거나 다른 식품 또는 식품 성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다.The health food composition of the present invention may be added to the rhododendron alboom extract or fractions thereof as it is, or used with other food or food ingredients, and may be suitably used according to a conventional method.
상기 건강식품용 조성물의 종류에는 특별한 제한은 없다. 상기 로도덴드론 알붐 추출물 또는 이의 분획물을 첨가할 수 있는 식품의 예로는 육류, 소시지, 빵, 초콜릿, 캔디류, 스넥류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 드링크제, 알코올음료 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 건강식품용 조성물을 모두 포함한다.There is no particular limitation on the kind of the composition for health food. Examples of foods to which the Rhododendron alboom extract or fractions thereof may be added include meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen, other noodles, dairy products including gum, ice cream, and various soups. , Beverages, tea, drinks, alcoholic beverages and vitamin complexes, etc., and includes all of the composition for health food in the conventional sense.
본 발명의 건강음료 조성물은 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 상술한 천연 탄수화물은 포도당, 과당과 같은 모노사카라이드, 말토스, 슈크로스와 같은 디사카라이드, 및 덱스트린, 사이클로덱스트린과 같은 폴리사카라이드, 자일리톨, 소르비톨, 에리트리톨 등의 당알콜이다. 감미제로서는 타우마틴, 스테비아 추출물과 같은 천연 감미제나, 사카린, 아스파르탐과 같은 합성 감미제 등을 사용할 수 있다. 상기 천연 탄수화물의 비율은 본 발명의 조성물 100 ㎖당 일반적으로 약 0.01 ~ 0.04 g, 바람직하게는 약 0.02 ~ 0.03 g 이다.The health beverage composition of the present invention may contain various flavors or natural carbohydrates as an additional ingredient such as ordinary beverages. Such natural carbohydrates are monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose, and polysaccharides such as dextrin and cyclodextrin, and sugar alcohols such as xylitol, sorbitol and erythritol. Examples of sweeteners include natural sweeteners such as tau martin and stevia extract, synthetic sweeteners such as saccharin and aspartame, and the like. The proportion of the natural carbohydrate is generally about 0.01 to 0.04 g, preferably about 0.02 to 0.03 g per 100 ml of the composition of the present invention.
상기 외에 본 발명의 건강식품용 조성물은 여러 가지 영양제, 비타민, 전해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산음료에 사용되는 탄산화제 등을 함유할 수 있다. 그 밖에 천연 과일주스, 과일주스 음료 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 또는 혼합하여 사용할 수 있다. 이러한 첨가제의 비율은 크게 중요하진 않지만 본 발명의 조성물 100 중량부당 0.01 ~ 0.1 중량부의 범위에서 선택되는 것이 일반적이다.In addition to the above, the composition for health food of the present invention includes various nutrients, vitamins, electrolytes, flavors, coloring agents, pectic acid and salts thereof, alginic acid and salts thereof, organic acids, protective colloidal thickeners, pH regulators, stabilizers, preservatives, glycerin , Alcohols, carbonating agents used in carbonated drinks, and the like. It may also contain flesh for the production of natural fruit juices, fruit juice drinks and vegetable drinks. These components may be used independently or in combination. The proportion of such additives is not critical but is generally selected in the range of 0.01 to 0.1 parts by weight per 100 parts by weight of the composition of the present invention.
본 발명의 로도덴드론 알붐 추출물 또는 이의 분획물은 유의적으로 DPPH 자유라디칼 소거 효과 및 ABTS 자유라디칼 소거 효과를 나타내어 탁월한 항산화 효과를 가지므로, 항산화용 건강식품용 조성물 또는 노화방지용 건강식품용 조성물의 유효성분으로 유용하게 사용될 수 있음을 알 수 있다.
Rhododendron alboom extract or fractions thereof of the present invention exhibits significant DPPH free radical scavenging effect and ABTS free radical scavenging effect, and thus has an excellent antioxidant effect, and thus is effective for antioxidant health food compositions or anti-aging health food compositions. It can be seen that it can be usefully used as a component.
아울러, 본 발명은 로도덴드론 알붐 추출물 또는 이의 분획물을 유효성분으로 함유하는 항산화용 화장료 조성물을 제공한다.In addition, the present invention provides a cosmetic composition for antioxidant containing Rhododendron alboom extract or fractions thereof as an active ingredient.
또한, 본 발명은 로도덴드론 알붐 추출물 또는 이의 분획물을 유효성분으로 함유하는 노화방지용 화장료 조성물을 제공한다.The present invention also provides an anti-aging cosmetic composition containing rhododendron alboom extract or fractions thereof as an active ingredient.
상기 화장료 조성물은, 예를 들면 용액, 겔, 고체 또는 반죽 무수 생성물, 수상에 유상을 분산시켜 얻은 에멀젼, 현탁액, 마이크로에멀젼, 마이크로캡슐, 미세과립구 또는 이온형(리포좀), 비이온형의 소낭 분산제의 형태, 크림, 스킨, 로션, 파우더, 연고, 스프레이 또는 콘실 스틱의 형태로 제공될 수 있다. 또한, 포말(foam)의 형태 또는 압축된 추진제를 더 함유한 에어로졸 조성물의 형태로도 제조될 수 있다.The cosmetic composition may be in the form of a solution, a gel, a solid or a paste anhydrous product, an emulsion obtained by dispersing an oil phase in water, a suspension, a microemulsion, a microcapsule, a microgranule or an ionic (liposome) A cream, a skin, a lotion, a powder, an ointment, a spray, or a cone stick. It may also be prepared in the form of a foam or in the form of an aerosol composition further containing a compressed propellant.
또한, 상기 화장료 조성물은 본 발명의 로도덴드론 알붐 추출물 또는 이의 분획물에 추가로 지방 물질, 유기 용매, 용해제, 농축제 및 겔화제, 연화제, 항산화제, 현탁화제, 안정화제, 발포제(foaming agent), 방향제, 계면활성제, 물, 이온형 또는 비이온형 유화제, 충전제, 금속이온봉쇄제 및 킬레이트화제, 보존제, 비타민, 차단제, 습윤화제, 필수 오일, 염료, 안료, 친수성 또는 친유성 활성제, 지질 소낭 또는 화장품에 통상적으로 사용되는 임의의 다른 성분과 같은 화장품 분야에서 통상적으로 사용되는 보조제를 함유할 수 있다.In addition, the cosmetic composition, in addition to the rhododendron alboom extract or fractions thereof of the present invention, fatty substances, organic solvents, solubilizers, thickening and gelling agents, emollients, antioxidants, suspending agents, stabilizers, foaming agents (foaming agents) , Fragrances, surfactants, water, ionic or nonionic emulsifiers, fillers, metal ion sequestrants and chelating agents, preservatives, vitamins, blockers, wetting agents, essential oils, dyes, pigments, hydrophilic or lipophilic active agents, lipid vesicles Or any other ingredient commonly used in cosmetics, such as auxiliaries commonly used in the cosmetic field.
본 발명의 로도덴드론 알붐 추출물 또는 이의 분획물을 함유하는 화장료 조성물에 있어서, 통상적으로 함유되는 화장료 조성물에 본 발명의 추출물 또는 이의 분획물이 0.1 내지 50 중량%, 바람직하게는 1 내지 10 중량%의 양으로 첨가될 수 있다.In the cosmetic composition containing the rhododendron alboom extract of the present invention or a fraction thereof, the amount of the extract or the fraction of the present invention is 0.1 to 50% by weight, preferably 1 to 10% by weight in the cosmetic composition usually contained Can be added.
본 발명의 로도덴드론 알붐 추출물 또는 이의 분획물을 피부 외용제로 사용하는 경우, 추가로 지방 물질, 유기 용매, 용해제, 농축제 및 겔화제, 연화제, 항산화제, 현탁화제, 안정화제, 발포제(foaming agent), 방향제, 계면활성제, 물, 이온형 또는 비이온형 유화제, 충전제, 금속이온 봉쇄제 및 킬레이트화제, 보존제, 비타민, 차단제, 습윤화제, 필수 오일, 염료, 안료, 친수성 또는 친유성 활성제, 지질 소낭 또는 피부용 외용제에 통상적으로 사용되는 임의의 다른 성분과 같은 피부 과학 분야에서 통상적으로 사용되는 보조제를 함유할 수 있다. 또한, 상기 성분들은 피부 과학 분야에서 일반적으로 사용되는 양으로 도입될 수 있다.When the Rhododendron alboom extract of the present invention or a fraction thereof is used as an external preparation for skin, it is further added to fatty substances, organic solvents, solubilizers, thickeners and gelling agents, emollients, antioxidants, suspending agents, stabilizers, foaming agents ), Fragrances, surfactants, water, ionic or nonionic emulsifiers, fillers, metal ion sequestrants and chelating agents, preservatives, vitamins, blockers, wetting agents, essential oils, dyes, pigments, hydrophilic or lipophilic active agents, lipids It may contain adjuvants commonly used in the field of dermatology, such as vesicles or any other ingredients conventionally used in external preparations for skin. In addition, the ingredients may be introduced in amounts generally used in the field of dermatology.
본 발명의 로도덴드론 알붐 추출물 또는 이의 분획물은 유의적으로 DPPH 자유라디칼 소거 효과 및 ABTS 자유라디칼 소거 효과를 나타내어 탁월한 항산화 효과를 가지므로, 항산화용 화장료 조성물 또는 노화방지용 화장료 조성물의 유효성분으로 유용하게 사용될 수 있음을 알 수 있다.
Rhododendron alboom extract or fractions thereof of the present invention exhibits significant anti-DPPH free radical scavenging effect and ABTS free radical scavenging effect, and thus has an excellent antioxidant effect, which is useful as an active ingredient of an antioxidant cosmetic composition or an anti-aging cosmetic composition. It can be seen that it can be used.
이하, 본 발명을 실시예, 실험예 및 제조예에 의하여 상세히 설명한다.Hereinafter, the present invention will be described in detail with reference to Examples, Experimental Examples and Production Examples.
단, 하기 실시예, 실험예 및 제조예는 본 발명을 구체적으로 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예, 실험예 및 제조예에 의해 한정되는 것은 아니다.
However, the following Examples, Experimental Examples and Preparation Examples are merely illustrative of the present invention in detail, and the content of the present invention is not limited to the following Examples, Experimental Examples, and Preparation Examples.
<실시예 1> 로도덴드론 알붐 ( Rhododendron album Blume ) 추출물 제조 Example 1 Rhododendron Alboom ( Rhododendron album Blume ) Extract Preparation
로도덴드론 알붐 추출물은 한국생명공학연구원 해외생물소재허브센터 의 해외식물추출물은행에서 구입하였으며, 한국생명공학연구원 식물표본관(KRIB, Herbarium of the Korea Research Institute of Bioscience and Biotechnology)에 증거표본(KRIB 0019989)이 보관되어 있다. 또한, 하기 실험은 로도덴드론 알붐 메탄올 추출물을 DMSO(dimethyl sulfoxide)에 20 mg/㎖의 농도가 되도록 용해시킨 후(이하 로도덴드론 알붐 추출물이라 함), 농도별로 희석하여 사용하였다.
The Rhododendron Alboom Extract was purchased from the Overseas Plant Extract Bank of the Korea Center for Biomaterials, Korea Research Institute of Bioscience and Biotechnology, and was provided at the Herbarium of the Korea Research Institute of Bioscience and Biotechnology (KRIB 0019989). ) Is stored. In addition, the following experiment was used to dissolve the Rhododendron alboom methanol extract to a concentration of 20 mg / ㎖ in DMSO (dimethyl sulfoxide) (hereinafter referred to as Rhododendron alboom extract), it was used by diluting by concentration.
<< 실시예Example 2> 2> 로도덴드론Rhododendron 알붐의Alboom 용매 menstruum 분획물Fraction 제조 Produce
상기 <실시예 1>에서 얻어진 로도덴드론 알붐 추출물 중 360 mg 에 증류수를 첨가하여 현탁시키고, 동량의 n-헥산을 가하여 혼합 후 n-헥산가용성 분획부와 물가용성 분획부를 분리하였으며, 이를 3회 실시하여 여과, 감압농축하여 n-헥산 분획물 17.2 mg을 수득하였다. 그런 다음, 상기 n-헥산 분획물을 제거하고 남은 물층에 클로로포름을 동량 가하여 같은 방법으로 클로로포름 분획물 21.0 mg 수득하였고, 다시 남은 물층에 에틸아세테이트를 동량 가하여 같은 방법으로 에틸아세테이트 분획물 14.0 mg을 수득하였으며, 또다시 남은 물층에 부탄올을 동량 가하여 동일한 방법으로 부탄올 분획물 47.3 mg을 수득하였으며, 남은 물층을 농축하여 물 분획물 235.5 mg을 수득하였다(도 1).
Suspended by adding distilled water to 360 mg of the Rhododendron alboom extract obtained in Example 1, and mixed with an equal amount of n-hexane, the n-hexane-soluble fraction and the water-soluble fraction were separated, and this was repeated three times. Filtration and concentration under reduced pressure gave 17.2 mg of n-hexane fractions. Then, by removing the n-hexane fraction and adding the same amount of chloroform to the remaining water layer to obtain 21.0 mg of the chloroform fraction in the same manner, to the remaining water layer was added to the same amount of ethyl acetate to give 14.0 mg of ethyl acetate fraction in the same manner. The same amount of butanol was added to the remaining water layer to obtain 47.3 mg of butanol fraction in the same manner, and the remaining water layer was concentrated to obtain 235.5 mg of water fraction (FIG. 1).
<< 실시예Example 3> 3> 로도덴드론Rhododendron 알붐Alboom 추출물 및 Extract and 분획물의Fraction TLCTLC 조사 Research
상기 <실시예 1>과 <실시예 2>에서 얻어진 로도덴드론 알붐 추출물 또는 이의 분획물을 10 mg/ml의 농도로 메탄올에 녹인 후 실리카겔 역상 크로마토그래피(TLC Silica gel 60 RP-18 F254S, Merck)를 실시하여 DPPH 및 ABTS 자유라디칼 소거 활성이 있는 에틸아세테이트, 부탄올 분획물질을 조사하였다. 전개용매는 메탄올 50%로 하였다(도 2).
Rhododendron alboom extract or fractions thereof obtained in <Example 1> and <Example 2> were dissolved in methanol at a concentration of 10 mg / ml, and then silica gel reversed phase chromatography (
<< 실시예Example 4> 4> 로도덴드론Rhododendron 알붐의Alboom 추출물, extract, 분획물의Fraction UPLCUPLC 분석 analysis
상기 <실시예 1>과 <실시예 2>에서 얻어진 로도덴드론 알붐 추출물 또는 이의 분획물을 10 mg/ml로 메탄올에 녹인 후 0.2 um의 멤브레인 필터(membrane filter)로 여과하였다. UPLC는 Waters Acquity UPLC 시스템을 이용하였으며, 컬럼은 ACQUITY UPLCTMBEHC18(10 mm × 2.1 mm, i.d., 1.7 μm, waters, 미국)을 35℃에서 사용하였으며, 이동상 A는 물과 포름산(formic acid)(100:0.1, v/v)으로 이동상 B는 아세토나이트릴(acetonitril)과 포름산(100:0.1,v/v)으로 하여 초기에 이동상 B를 10%로 1분동안 유지시킨 후, 5분까지 45%로 증가, 7.5분까지 100%로 이동상 B를 증가시켜 분석 한 후, 이동상 B를 100%로 9분까지 유지시키고, 9.5분까지 이동상 B를 10%로 낮추고 11분까지 10%로 안정화시켜 분석에 사용하였다. 이동상의 유속량은 0.4 ml/min 그리고 시료 주입량은 3μl로 하였다. The rhododendron alboom extract obtained in <Example 1> and <Example 2> or a fraction thereof was dissolved in methanol at 10 mg / ml and filtered through a 0.2 um membrane filter. UPLC was used Waters Acquity UPLC system, column was ACQUITY UPLC TM BEHC 18 (10 mm x 2.1 mm, id, 1.7 μm, waters, USA) at 35 ℃, mobile phase A is water and formic acid Mobile phase B with (100: 0.1, v / v) was acetonitrile and formic acid (100: 0.1, v / v) and initially maintained mobile phase B at 10% for 1 minute and then until 5 minutes. After analyzing by increasing mobile phase B to 45%, increasing mobile phase B to 100% by 7.5 minutes, maintaining mobile phase B to 100% for 9 minutes, lowering mobile phase B to 10% by 9.5 minutes and stabilizing to 10% by 11 minutes. Used for analysis. The flow rate of the mobile phase was 0.4 ml / min and the sample injection amount was 3 μl.
CAD(Charge Aerosol Detector)는 UPLC로부터 분리되어진 물질들에 전하(Charge)를 붙여주어 그 전하를 측정하는 탐지기(detector)로써 크로마토그래피 형식으로 물질의 상대적 함량과 분리도를 확인해 볼 수 있다(도 3). CAD (Charge Aerosol Detector) is a detector that measures the charge by attaching a charge to the materials separated from the UPLC, and can check the relative content and the degree of separation in the chromatographic form (FIG. 3). .
<실험예 1> 로도덴드론 알붐 추출물의 DPPH 자유라디칼 소거 효과 확인 Experimental Example 1 Rhododendron DPPH of Alboom Extract Check free radical scavenging effect
상기 <실시예 1>의 로도덴드론 알붐 추출물의 자유라디칼 소거 효과를 1,1-디페닐-2-피크릴-히드라질(1,1-diphenyl-2-picryl-hydrazyl, DPPH, Sigma) 방법으로 측정하였다. 1,1-diphenyl-2-picryl-hydrazyl (1,1-diphenyl-2-picryl-hydrazyl, DPPH, Sigma) method of the free radical scavenging effect of the Rhododendron alboom extract of <Example 1> Measured by.
구체적으로, 자유라디칼 소거 효과를 측정하기 위해, 에탄올에 희석한 0.15 mM의 DPPH 용액 90 ㎕을 96웰 플레이트(well plate)에 넣고, 상기 로도덴드론 알붐 추출물을 2.5, 5, 10, 20, 40 및 80 ㎍/㎖ 의 농도로 각각 분주하여, 상온에서 20분간 방치하였다. 그 후에 마이크로플레이트 측정기(microplate Reader)로 517 nm에서 반응물의 흡광도를 측정하였다. 자유라디칼 소거 효과(%)는 하기의 수학식 1로 산출하였다. 이때, DMSO를 처리한 군을 음성대조군으로, 합성 항산화제인 BHA와 천연 항산화제인 토코페롤을 처리한 군을 양성대조군으로 사용하였다.
Specifically, in order to measure the free radical scavenging effect, 90 μl of 0.15 mM DPPH solution diluted in ethanol was put in a 96 well plate, and the Rhododendron alboom extract was 2.5, 5, 10, 20, 40 And 80 µg / ml each was dispensed and left for 20 minutes at room temperature. The absorbance of the reactants was then measured at 517 nm with a microplate reader. The free radical scavenging effect (%) was calculated by Equation 1 below. At this time, the DMSO-treated group was used as a negative control group, the group treated with a synthetic antioxidant BHA and a natural antioxidant tocopherol was used as a positive control group.
A; 본 발명의 로도덴드론 알붐 추출물을 처리하지 않은 음성대조군의 흡광도; 및A; Absorbance of the negative control group not treated Rhododendron alboom extract of the present invention; And
B; 본 발명의 로도덴드론 알붐 추출물을 처리한 실험군의 흡광도
B; Absorbance of Experimental Group Treated with Rhododendron Alboom Extract of the Present Invention
그 결과, 도 4에 나타낸 바와 같이, DPPH 자유라디칼 소거 효과가 로도덴드론 알붐 추출물의 농도에 의존적임을 확인하였고, 또한 로도덴드론 알붐 추출물의DPPH 자유라디칼 소거 능력이 양성대조군인 토코페롤보다 월등히 우수하며, 합성대조군인 BHA와 활성이 유사함을 확인하였다(도 4).
As a result, as shown in Figure 4, it was confirmed that the DPPH free radical scavenging effect is dependent on the concentration of the rhododendron alboom extract, and also the DPPH free radical scavenging ability of the rhododendron alboom extract is significantly superior to the tocopherol positive control group. , It was confirmed that the activity similar to the synthetic control BHA (Fig. 4).
<실험예 2> 로도덴드론 알붐 추출물의 ABTS 자유라디칼 소거 효과 확인 Experimental Example 2 Rhododendron ABTS of Alboom Extract Check free radical scavenging effect
상기 <실시예 1>의 로도덴드론 알붐 추출물을 이용하여 ABTS 자유라디칼 소거 활성을 확인하였다.ABTS free radical scavenging activity was confirmed using the Rhododendron Alboom extract of <Example 1>.
구체적으로, ABTS와 포타슘 퍼설페이트(potassium persulfate)를 각각 7 mM과 2.45 mM이 되도록 제조하고 혼합한 후, 암소에서 12시간 방치하여 ABTS 자유라디칼을 형성시켰다. 이를 734 nm에서 흡광도가 0.7이 되도록 증류수로 희석한 후 96웰 플레이트에 분주하고, 여기에 로도덴드론 알붐 추출물을 2.5, 5, 10, 20, 40 및 80 ㎍/㎖의 농도로 분주한 후, 상온의 암소에서 7분간 반응시켰다. 흡광도는 734 nm에서 마이크로플레이트 측정기를 이용하여 측정하였다. 이때, DMSO를 처리한 군을 음성대조군으로, 토코페롤과 BHA를 처리한 군을 양성대조군으로 사용하였다.Specifically, ABTS and potassium persulfate were prepared to be 7 mM and 2.45 mM, respectively, mixed, and then left in the dark for 12 hours to form ABTS free radicals. This was diluted with distilled water so that the absorbance was 0.7 at 734 nm, and the plate was dispensed into 96-well plates, and the rhododendron alboom extract was dispensed at concentrations of 2.5, 5, 10, 20, 40, and 80 μg / ml. The reaction was carried out for 7 minutes in a dark room temperature. Absorbance was measured using a microplate meter at 734 nm. At this time, the DMSO-treated group was used as a negative control group, the tocopherol and BHA-treated group was used as a positive control group.
그 결과, 도 5에서 나타낸 바와 같이, ABTS 자유라디칼 소거 효과가 로도덴드론 알붐 추출물의 농도에 의존적임을 확인하였고, 양성대조군인 토코페롤과 비교하였을 때 로도덴드론 알붐 추출물의 ABTS 라디칼 소거 효과가 우수함을 확인하였다(도 5).
As a result, as shown in Figure 5, it was confirmed that the ABTS free radical scavenging effect is dependent on the concentration of the rhododendron alboom extract, the ABTS radical scavenging effect of the rhododendron alboom extract is excellent when compared to the positive control tocopherol It was confirmed (FIG. 5).
<< 실험예Experimental Example 3> 3> 로도덴드론Rhododendron 알붐Alboom 용매 menstruum 분획물의Fraction DPPHDPPH 및 And ABTSABTS 자유라디칼Free radical 소거능Scatters 확인 Confirm
상기 <실시예 2>에서 분획한 로도덴드론 알붐 용매별 n-헥산, 클로로포름, 에틸아세테이트, 부탄올, 물 분획물에 대해 <실험예 1> 및 <실험예 2>와 동일한 방법으로 DPPH 및 ABTS 자유라디칼 소거능을 측정하였다. For n-hexane, chloroform, ethyl acetate, butanol, and water fractions of the rhododendron alboom solvents fractionated in <Example 2>, DPPH and ABTS free radicals were prepared in the same manner as in <Experimental Example 1> and <Experimental Example 2>. Scavenging ability was measured.
구체적으로, 상기 분획한 각 분획물은 40 ㎍/㎖의 농도로 각각 분주하여, 상온에서 반응시킨 후, 마이크로플레이트 흡광기로 흡광도를 측정하였다. 이때, DMSO를 처리한 군을 음성대조군으로, 천연항산화제인 a-토코페롤과 아스코르브산 또는 합성항산화제인 BHA를 처리한 군을 양성대조군으로 사용하였다. Specifically, each fraction was fractionated at a concentration of 40 ㎍ / ㎖, respectively, and reacted at room temperature, the absorbance was measured by a microplate absorber. At this time, the DMSO-treated group was used as a negative control group, a-tocopherol as a natural antioxidant and ascorbic acid or a group treated with BHA as a synthetic antioxidant was used as a positive control group.
그 결과, 표 1에서 나타난 바와 같이, 로도덴드론 알붐 용매 분획물은 DPPH 및 ABTS 자유라디칼 소거 효과가 뛰어남을 확인하였고, 특히 로도덴드론 알붐 에틸아세테이트, 부탄올 분획물은 DPPH 및 ABTS 자유라디칼 소거 효과가 현저히 높은 것을 확인하였으며, 또한 천연물 유래의 양성대조군인 a-토코페롤과 아스코르브산을 처리한 군과 비교하였을 때도 월등히 우수한 활성을 나타냄을 확인하였다(표 1).
As a result, as shown in Table 1, it was confirmed that the rhododendron alboom solvent fractions were excellent in DPPH and ABTS free radical scavenging effects, and in particular, the rhododendron alboom ethyl acetate and butanol fractions were remarkably effective in DPPH and ABTS free radical scavenging effects. It was confirmed that the high, and also compared to the group treated with a-tocopherol and ascorbic acid, which is a positive control group derived from natural products, it was confirmed to show an excellent activity (Table 1).
<< 제조예Manufacturing example 1> 1> 로도덴드론Rhododendron 알붐Alboom 추출물 또는 이의 Extract or its 분획물을The fraction 유효성분으로 함유하는 Contains as an active ingredient 항산화용 약학적 조성물의 제조Preparation of Antioxidant Pharmaceutical Compositions
<1-1> <1-1> 산제의Sanje 제조 Produce
본 발명의 로도덴드론 알붐 추출물 또는 이의 분획물 2 g2 g of rhododendron alboom extract of the present invention or a fraction thereof
유당 1 g1 g lactose
상기의 성분을 혼합하고 기밀포에 충진하여 산제를 제조하였다.
The above components were mixed and packed in airtight bags to prepare powders.
<1-2> 정제의 제조<1-2> Preparation of tablets
본 발명의 로도덴드론 알붐 추출물 또는 이의 분획물 100 ㎎Rhododendron alboom extract of the present invention or a fraction thereof 100 mg
옥수수전분 100 ㎎
유 당 100 ㎎
스테아린산 마그네슘 2 ㎎2 mg magnesium stearate
상기의 성분을 혼합한 후, 통상의 정제의 제조방법에 따라서 타정하여 정제를 제조하였다.
After mixing the above components, tablets were prepared by tableting according to a conventional method for producing tablets.
<1-3> 캡슐제의 제조≪ 1-3 > Preparation of capsules
본 발명의 로도덴드론 알붐 추출물 또는 이의 분획물 100 ㎎Rhododendron alboom extract of the present invention or a fraction thereof 100 mg
옥수수전분 100 ㎎
유 당 100 ㎎
스테아린산 마그네슘 2 ㎎2 mg magnesium stearate
상기의 성분을 혼합한 후, 통상의 캡슐제의 제조방법에 따라서 젤라틴 캡슐에 충전하여 캡슐제를 제조하였다.
After mixing the above components, the capsules were filled in gelatin capsules according to the conventional preparation method of capsules.
<1-4> 환의 제조≪ 1-4 >
본 발명의 로도덴드론 알붐 추출물 또는 이의 분획물 1 gRhododendron alboom extract of the present invention or fraction thereof 1 g
유당 1.5 gLactose 1.5 g
글리세린 1 g1 g of glycerin
자일리톨 0.5 gXylitol 0.5 g
상기의 성분을 혼합한 후, 통상의 방법에 따라 1환 당 4 g이 되도록 제조하였다.
After mixing the above components, they were prepared so as to be 4 g per one ring according to a conventional method.
<1-5> 과립의 제조<1-5> Preparation of granules
본 발명의 로도덴드론 알붐 추출물 또는 이의 분획물 150 ㎎Rhododendron alboom extract of the present invention or fraction thereof 150 mg
대두추출물 50 ㎎Soy extract 50 mg
포도당 200 ㎎
전분 600 ㎎
상기의 성분을 혼합한 후, 30% 에탄올 100 ㎎을 첨가하여 섭씨 60℃에서 건조하여 과립을 형성한 후 포에 충진하였다.
After mixing the above components, 100 mg of 30% ethanol was added and the mixture was dried at 60 캜 to form granules, which were then filled in a capsule.
<< 제조예Manufacturing example 2> 2> 로도덴드론Rhododendron 알붐Alboom 추출물 또는 이의 Extract or its 분획물을The fraction 유효성분으로 함유하는 항산화용 건강식품의 제조 Preparation of Antioxidant Health Foods Containing as an Active Ingredient
<2-1> 밀가루 식품의 제조<2-1> Production of flour food
본 발명의 로도덴드론 알붐 추출물 또는 이의 분획물 0.5~5.0 중량부를 밀가루에 첨가하고, 이 혼합물을 이용하여 빵, 케이크, 쿠키, 크래커 및 면류를 제조하였다.
0.5 to 5.0 parts by weight of the rhododendron alboom extract or fractions thereof of the present invention was added to flour, and bread, cake, cookies, crackers and noodles were prepared using this mixture.
<2-2> <2-2> 스프soup 및 육즙( And juicy ( graviesgravies )의 제조Manufacturing
본 발명의 로도덴드론 알붐 추출물 또는 이의 분획물 0.1~5.0 중량부를 스프 및 육즙에 첨가하여 건강 증진용 육가공 제품, 면류의 수프 및 육즙을 제조하였다.
0.1 to 5.0 parts by weight of the rhododendron alboom extract or fractions thereof of the present invention was added to soups and broths to prepare meat products for health promotion, soups and noodles for noodles.
<2-3> 그라운드 <2-3> Ground 비프(ground beef)의Beef 제조 Produce
본 발명의 로도덴드론 알붐 추출물 또는 이의 분획물 10 중량부를 그라운드 비프에 첨가하여 건강 증진용 그라운드 비프를 제조하였다.
10 parts by weight of the Rhododendron alboom extract of the present invention or a fraction thereof was added to the ground beef to prepare a ground beef for health promotion.
<2-4> 유제품(<2-4> Dairy products ( dairydairy productsproducts )의 제조Manufacturing
본 발명의 로도덴드론 알붐 추출물 또는 이의 분획물 5~10 중량부를 우유에 첨가하고, 상기 우유를 이용하여 버터 및 아이스크림과 같은 다양한 유제품을 제조하였다.
5-10 parts by weight of the rhododendron alboom extract or fractions thereof of the present invention was added to milk, and various dairy products such as butter and ice cream were prepared using the milk.
<2-5> <2-5> 선식의Solar 제조 Produce
현미, 보리, 찹쌀, 율무를 공지의 방법으로 알파화시켜 건조시킨 것을 배전한 후 분쇄기로 입도 60 메쉬의 분말로 제조하였다.Brown rice, barley, glutinous rice, and yulmu were dried by a known method and dried, and the mixture was granulated to a powder having a particle size of 60 mesh.
검정콩, 검정깨, 들깨도 공지의 방법으로 쪄서 건조시킨 것을 배전한 후 분쇄기로 입도 60 메쉬의 분말로 제조하였다.Black soybeans, black sesame seeds, and perilla seeds were steamed and dried by a conventional method, and then they were prepared into powder having a particle size of 60 mesh by a pulverizer.
본 발명의 로도덴드론 알붐 추출물 또는 이의 분획물을 진공 농축기에서 감압농축하고, 분무, 열풍건조기로 건조하여 얻은 건조물을 분쇄기로 입도 60 메쉬로 분쇄하여 건조분말을 얻었다.The Rhododendron alboom extract of the present invention or a fraction thereof was concentrated under reduced pressure in a vacuum concentrator, and the dried product obtained by spraying and drying with a hot air dryer was pulverized with a particle size of 60 mesh to obtain a dry powder.
상기에서 제조한 곡물류, 종실류 및 본 발명의 로도덴드론 알붐 추출물을 다음의 비율로 배합하여 제조하였다:The grains, seeds and the Rhododendron alboom extract of the present invention prepared above were formulated in the following proportions:
곡물류(현미 30 중량부, 율무 15 중량부, 보리 20 중량부),(30 parts by weight of brown rice, 15 parts by weight of yulmu, 20 parts by weight of barley)
종실류(들깨 7 중량부, 검정콩 8 중량부, 검정깨 7 중량부),Seeds (7 parts by weight of perilla, 8 parts by weight of black beans, 7 parts by weight of black sesame seeds)
본 발명의 로도덴드론 알붐 추출물 또는 이의 분획물(3 중량부),Rhododendron alboom extract of the present invention or a fraction thereof (3 parts by weight),
영지(0.5 중량부),(0.5 part by weight),
지황(0.5 중량부).
Rhubarb (0.5 parts by weight).
<< 제조예Manufacturing example 3> 3> 로도덴드론Rhododendron 알붐Alboom 추출물 또는 이의 Extract or its 분획물을The fraction 유효성분으로 함유하는 항산화용 음료의 제조 Preparation of antioxidant drink containing as an active ingredient
<3-1> <3-1> 건강음료의Health drink 제조 Produce
액상과당(0.5%), 올리고당(2%), 설탕(2%), 식염(0.5%), 물(75%)과 같은 부재료와 본 발명의 로도덴드론 알붐 추출물 또는 이의 분획물 5 g을 균질하게 배합하여 순간 살균을 한 후 이를 유리병, 패트병 등 소포장 용기에 포장하여 제조하였다.
Homogeneously subcomponents such as liquid fructose (0.5%), oligosaccharides (2%), sugar (2%), salt (0.5%), water (75%) and 5 g of rhododendron alboom extract or fractions thereof of the present invention. After sterilization by mixing, it was prepared by packaging in a small packaging container such as glass bottles, plastic bottles.
<3-2> 야채 주스의 제조<3-2> Preparation of vegetable juice
본 발명의 로도덴드론 알붐 추출물 또는 이의 분획물 5 g을 토마토 또는 당근 주스 1,000 ㎖에 가하여 야채 주스를 제조하였다.
Vegetable juice was prepared by adding 5 g of rhododendron alboom extract of the present invention or a fraction thereof to 1,000 ml of tomato or carrot juice.
<3-3> 과일 주스의 제조<3-3> Production of fruit juice
본 발명의 로도덴드론 알붐 추출물 또는 이의 분획물 1 g을 사과 또는 포도 주스 1,000 ㎖ 에 가하여 과일 주스를 제조하였다.
1 g of rhododendron alboom extract of the present invention or a fraction thereof was added to 1,000 ml of apple or grape juice to prepare a fruit juice.
<< 제조예Manufacturing example 4> 4> 로도덴드론Rhododendron 알붐Alboom 추출물 또는 이의 Extract or its 분획물을The fraction 유효성분으로 함유하는 항산화용 Antioxidant containing as an active ingredient 화장료의Cosmetic 제조 Produce
<4-1> 유연 화장수의 제조<4-1> Preparation of flexible lotion
상기 <실시예 1> 또는 <실시예 2>의 로도덴드론 알붐 추출물 또는 이의 분획물을 유효성분으로 함유하는 유연 화장수는 하기 [표 2]와 같이 제조하였다.The flexible lotion containing the rhododendron alboom extract of <Example 1> or <Example 2> or a fraction thereof as an active ingredient was prepared as shown in [Table 2].
<4-2> 영양 크림의 제조<4-2> Preparation of nourishing cream
상기 <실시예 1> 또는 <실시예 2>의 로도덴드론 알붐 추출물 또는 이의 분획물을 유효성분으로 함유한 영양크림은 하기 [표 3]의 조성과 같이 제조하였다. The nourishing cream containing Rhododendron alboom extract of <Example 1> or <Example 2> or a fraction thereof as an active ingredient was prepared as shown in [Table 3].
Claims (8)
Rhododendron album ) Pharmaceutical composition for antioxidant containing extract or fractions thereof as an active ingredient.
The method of claim 1, wherein the rhododendron alboom extract is water, C 1 Pharmaceutical composition for antioxidant, characterized in that the extraction using a lower alcohol or a mixture of C 2 ~ as a solvent.
The pharmaceutical composition for antioxidant according to claim 2, wherein the lower alcohol is ethanol or methanol.
The method of claim 1, wherein the fraction is obtained by suspending the rhododendron alboom extract in water, and then sequentially fractionated with normal-hexane, chloroform, ethyl acetate, normal-butanol and water. Antioxidant pharmaceutical composition, characterized in that any one of the acetate fraction, normal-butanol fraction or water fraction.
Rhododendron alboom extract or a composition for antioxidant health food containing the fraction thereof as an active ingredient.
The composition of claim 5, wherein the Rhododendron alboom extract is extracted using water, ethanol or a mixture thereof as a solvent.
The method of claim 5, wherein the fraction is obtained by suspending the rhododendron alboom extract in water, and then sequentially fractionated with normal-hexane, chloroform, ethyl acetate, normal-butanol and water. Antioxidant health food composition, characterized in that any one of the acetate fraction, normal-butanol fraction or water fraction.
Rhododendron alboom extract or cosmetic composition for antioxidant containing the fraction as an active ingredient.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20110070461 | 2011-07-15 | ||
KR1020110070461 | 2011-07-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20130009649A true KR20130009649A (en) | 2013-01-23 |
KR101425047B1 KR101425047B1 (en) | 2014-07-31 |
Family
ID=47839349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020120075544A KR101425047B1 (en) | 2011-07-15 | 2012-07-11 | Composition for antioxidant comprising extract or fractions of Rhododendron album Blume as an active ingredient |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101425047B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10577028B2 (en) | 2016-02-19 | 2020-03-03 | Nippon Steel Corporation | Automobile member |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100829722B1 (en) * | 2006-10-30 | 2008-05-15 | 주식회사 코리아나화장품 | Cosmetic Composition for Protecting Skin Aging Comprising the Extract of Root from Rhododendron mucronulatum as Active Ingredient |
-
2012
- 2012-07-11 KR KR1020120075544A patent/KR101425047B1/en active IP Right Grant
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10577028B2 (en) | 2016-02-19 | 2020-03-03 | Nippon Steel Corporation | Automobile member |
Also Published As
Publication number | Publication date |
---|---|
KR101425047B1 (en) | 2014-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20150019672A (en) | Composition for skin cell regeneration, anti-wrinkle, antioxidant, and skin whitening | |
KR101125224B1 (en) | A composition for skin anti-aging comprising extracts or fractions of Eremochloa ophiuroides as an active ingredient | |
KR102052523B1 (en) | A composition having anti-bacterial activity comprising Selaginella tamariscina extracts, fractions thereof or compounds isolated therefrom as an active ingredient | |
KR20150019680A (en) | Composition for skin cell regeneration, anti-wrinkle and antioxidant | |
KR101988909B1 (en) | Composition for skin cell regeneration, anti-wrinkle, antioxidant, anti-imflamation, and skin whitening | |
KR101425047B1 (en) | Composition for antioxidant comprising extract or fractions of Rhododendron album Blume as an active ingredient | |
KR20120073720A (en) | Composition for antiaging comprising the extract of dipterocarpus obtusifolius teijsm. ex miq. as an active ingredient | |
KR101425560B1 (en) | Composition for antioxidant comprising extracts or its fractions of Elaeocarpus petiolatus as an active ingredient | |
KR101661423B1 (en) | anti-oxidant and anti-inflammation composition extracted from Isodon excisus, and its extracting method | |
KR101440483B1 (en) | Composition for antiaging comprising extract or fraction of Ardisia tinctoria Pit. as an active ingredient | |
KR101416572B1 (en) | Composition for antiaging comprising extract or fractions of Mastixia arborea C.B.Clarke as an active ingredient | |
KR101988988B1 (en) | Composition for skin cell regeneration, anti-wrinkle, antioxidant and skin whitening | |
KR102001048B1 (en) | Composition for skin cell regeneration, anti-wrinkle, antioxidant and skin whitening | |
KR101909740B1 (en) | Composition for skin cell regeneration, anti-wrinkle, antioxidant and skin whitening comprising Monotropein | |
KR101988907B1 (en) | Composition for skin cell regeneration, anti-wrinkle, antioxidant, anti-imflamation, and skin whitening | |
KR102015375B1 (en) | Composition for antioxidant and skin whitening | |
KR101433726B1 (en) | Composition for antiaging comprising extracts or fractions of Diospyros blancoi A. DC. as an active ingredient | |
WO2013002522A2 (en) | Anti-aging composition containing a mastixia arborea c.b.clarke extract or a fraction thereof as an active ingredient | |
KR20220156164A (en) | Antioxidant or anti-inflammatory composition containing jujube seed extract or buckwheat leaf extract | |
KR101989009B1 (en) | Composition for skin cell regeneration, anti-wrinkle and antioxidant | |
KR102132627B1 (en) | Cosmetic composition containing Oriental Herb Fragrance Active Component Valencene for Skin Benefit Ingredient | |
KR102031664B1 (en) | Cosmetic composition containing Oriental Herb Fragrance Active Component 8-heptadecene for Skin Benefit Ingredient | |
KR101988908B1 (en) | Composition for skin cell regeneration, anti-wrinkle, antioxidant, anti-imflamation, and skin whitening | |
KR20150057757A (en) | Cosmetic composition containing Oriental Herb Fragrance Active Component Sabinene for Skin Benefit Ingredient | |
KR20150057763A (en) | Cosmetic composition containing Oriental Herb Fragrance Active Component Tridecane for Skin Benefit Ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |